NSEAnalysts/Institutional Investor Meet/Con. Call Updates23 Oct 2026 · 23 Oct 2026, 06:11 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Zota Health Care LImited · ZOTA
✦ AI SummaryResults
Zota Health Care Limited has informed the Exchange about the Intimation of Schedule of Earnings Conference Call on Q2FY27 Results. The company will host an Earnings Call on Q2FY27 Results on Thursday, October 29, 2026, at 12:00 hrs. (IST).
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
ZOTA: Zota Health Care Limited has informed the Exchange about the Intimation of Schedule of Earnings Conference Call on Q2FY27 Results
Attachments (1)
📄pdf
Download →
ZOTA_23102026180702_EarningsCall23102026.pdf
View document text
October 23, 2026
The Manager,
Listing Department,
The National Stock Exchange of India Limited
Exchange Plaza,
Bandra Kurla Complex,
Bandra (E), Mumbai- 400051
Dear Sir/Madam,
Trading Symbol: ZOTA
Sub: Intimation of Schedule of Earnings Conference Call on Q2FY27 Results
Ref.: Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015
With reference to the captioned subject; we, Zota Health Care Limited (the “Company”), would like to
inform you that the Company will host an Earnings Call on Q2FY27 Results on Thursday, October 29,
2026 at 12:00 hrs. (IST).
The conference call invitation is enclosed herewith.
This is for your information and record.
Thanking you,
Yours faithfully,
For Zota Health Care Limited
Ashvin Variya
(Group Company Secretary & Compliance Officer)
Place: Surat
Registered Office:
Zota House, 2/896, Hira Modi Street,
Sagrampura, Surat-395002 Ph: +91 261 2331601
Email: info@zotahealthcare.com
Web: www.zotahealthcare.com
CIN: L24231GJ2000PLC038352
Press Release – Q2FY22
Earnings Call Invite
Q2FY27
Zota Health Care Limited Q2FY27 Earnings Call to be held on Thursday, October 29, 2026,
at 12:00 hrs IST.
Surat, October 23, 2026: Zota Health Care Limited, one of the leading pharmaceutical Company with an aim to provide
affordable, high-quality, generic medicines predominantly for chronic conditions, in addition to proprietary medicinal,
OTC, ayurvedic, cosmetic, and nutraceutical products, will announce financial results for the second quarter and half
year ended September 30, 2026 on October 28, 2026. Following the announcement, the management of the
Company will host an Earnings Call on Thursday, October 29, 2026, at 12:00 HRS. (IST).
The Details of Q2FY27 Earnings Call are:
Date: Thursday, October 29, 2026
Time: 12:00 hrs. IST
Duration: 60 minutes
Dial-in Details:
Participants are encouraged to dial in 10 minutes prior to the call start time to avoid last-minute hold times. If you
reach an operator during the dial-in process, please inform them that you would like to join the “Zota Health Care
Limited Q2FY27 Earnings Conference Call’.
Universal Dail in numbers +91 22 6280 1107 / +91 22 7115 8008
Pre-Registration Facility • Step 1: Pre-register here. You will receive an email confirmation with
the call details on the registered email address.
• Step 2: Dial into the call on the Conference Call date, you will be
directly connected to the call.
Management Representation from Zota Health Care Limited
Mr. Himanshu Zota - Founder and Whole-time Director
Mr. Moxesh Zota - Managing Director
Dr. Sujit Paul - Group Chief Executive Officer
About Zota Health Care Limited:
Zota Health Care Ltd. (Zota), listed on the NSE, has been a key player in the Indian healthcare industry since 2000. Headquartered
in Surat, Zota's team of over 635 professionals drives its growth and strong market presence. The company specializes in the
development, manufacturing, and marketing of high-quality pharmaceutical, ayurvedic, nutraceutical, and over-the-counter
products.
ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q2FY2027 EARNINGS CALL INVITE | PAGE 1 OF 2
Press Release – Q2FY22
Earnings Call Invite
Q2FY27
Zota operates through three main divisions: marketing, export, and the retail pharmacy chain. In 2017, Zota launched Davaindia,
a generic pharmacy chain offering over 2,000 SKUs of quality medicines. Davaindia's strategic business model ensures efficient
management of the entire product life cycle through backward and forward integration.
Zota is renowned for its innovative Research and Development team, consistently investing in pioneering healthcare solutions,
reinforcing its reputation in the industry. For more information, visit: www.zotahealthcare.com
For details please contact:
Ashvin Variya Ajit Mishra Siddesh Chawan
Group Company Secretary & Compliance Officer Ernst & Young LLP, Ernst & Young LLP,
Zota Health Care Ltd Investor Relations Investor Relations
E: cszota@zotahealthcare.com E: Ajit.J.Mishra@in.ey.com E: Siddesh.Chawan@in.ey.com
Disclaimer: Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain
risks and uncertainties like government actions, local, political, or economic developments, technological risks, and many other factors that could cause actual
results to differ materially from those contemplated by the relevant forward-looking statements. Zota Health Care Ltd. will not be in any way responsible for any
action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or
circumstances.
ZOTA HEALTHCARE LIMITED | WWW.ZOTAHEALTHCARE.COM | Q2FY2027 EARNINGS CALL INVITE | PAGE 2 OF 2